Pricing Log in Create free account
Friday 6 November 2026 Export NVO’s income statement to Excel — free account

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.

Revenue
+4.47%
EPS
−18.7%
Free cash flow
+71.6%
Total debt
+44.4%

Quarter to June 2026, against a year earlier

40.33 1.85 −4.39%
Market cap
$134.8B
P/E
9.9×
Fwd P/E
—
Dividend yield
4.45%
F-score
5/9
Altman Z
4.32
Beneish M
−2.51
Dividend safety
46/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Novo Nordisk A/S (NVO) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Novo Nordisk A/S (NVO) trades at a EV/EBITDA of 7.3×. Over the past ten years it has ranged from 6.8× (October 2026) to 37.6× (June 2024); the current reading is higher than 1% of that period. That is below the Drug Manufacturers General industry median of 14.8× and below the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 10.6× (42.22%)
FY2024 18.4× (34.54%)
FY2023 28.1× 5.41%
FY2022 26.7× 6.13%
FY2021 25.1× 41.64%
FY2020 17.7× 13.86%
FY2019 15.6× 11.65%
FY2018 14.0× (15.64%)
FY2017 16.5× 44.56%
FY2016 11.4× (39.07%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 8.6× 24.81%
Mar 2026 6.9× (35.41%)
Dec 2025 10.6× (5.30%)
Sep 2025 11.2× (17.93%)
42 more quarters

Against its own ten years

Low 6.8× High 37.6×
Ten-year median 17.2×
Current reading's percentile 1

EV/EBITDA against peers

Company EV/EBITDA
NVO Novo Nordisk A/S 7.3×
GSK GSK PLC Sponsored ADR compare 10.6×
PFE Pfizer Inc. compare 10.9×
BMY Bristol Myers Squibb Company compare 11.3×
SNY Sanofi compare 11.4×
AZN AstraZeneca PLC compare 14.8×
NVS Novartis AG compare 15.6×
AMGN Amgen Inc. compare 17.6×
GILD Gilead Sciences, Inc. compare 505×
Drug Manufacturers General industry median 14.8×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on NVO